Neuphoria Therapeutics Inc. (NEUP) SEC Filings — 2025
19 SEC filings for Neuphoria Therapeutics Inc. (NEUP) in 2025.
Filings
- Neuphoria Therapeutics Faces Delisting Notice — 8-K · Dec 18, 2025
- Neuphoria Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Dec 17, 2025
- Neuphoria Therapeutics Inc. DEFA14A Filing — DEFA14A · Dec 8, 2025
- Neuphoria Responds to Lynx1's Revised Offer — DEFA14A · Dec 4, 2025
- Neuphoria Fires Back at Lynx1, Exposes 'False Narratives' — DEFA14A · Dec 1, 2025
- Neuphoria Therapeutics Files Definitive Additional Materials — DEFA14A · Nov 25, 2025
- Neuphoria Therapeutics Files Definitive Proxy Materials — DEFA14A · Nov 24, 2025
- Neuphoria's Net Loss Skyrockets to $9.9M Amid R&D Surge — 10-Q · Nov 14, 2025
- Neuphoria Therapeutics Initiates Strategic Review — DEFA14A · Nov 12, 2025
- NEUP Sets Virtual Annual Meeting, Board Seeks Re-election of Two Directors — DEF 14A · Oct 30, 2025
- Neuphoria Therapeutics Inc. Files 8-K with Key Corporate Updates — 8-K · Oct 27, 2025
- Neuphoria Therapeutics Files 8-K — 8-K · Oct 20, 2025
- Neuphoria Advances BNC210 to Phase 3 for SAD, PTSD; Nabs $15M Merck Milestone — 10-K · Sep 29, 2025
- Neuphoria Therapeutics Faces Delisting Concerns — 8-K · Sep 16, 2025
- Neuphoria Therapeutics Faces Delisting Notice — 8-K · Jul 18, 2025
- Neuphoria Therapeutics Files 8-K on Financials — 8-K · May 20, 2025
- Neuphoria Therapeutics Inc. Files Q3 2025 10-Q — 10-Q · May 20, 2025
- Neuphoria Therapeutics Files 10-Q for Q2 2024 — 10-Q · Feb 14, 2025
- Neuphoria Therapeutics Files 8-K — 8-K · Jan 14, 2025